Study finds early marker for kidney failure:
This article was originally published in Clinica
A US study has found a protein that might help diagnose kidney failure quickly and early in children who have undergone heart surgery. Testing for high levels of the marker neutrophil gelatinase-associated lipocalin in serum or urine could diagnose kidney failure in two hours, versus one to three days using the current serum creatinine test, according to findings published in The Lancet (April 2). "Effective therapeutic measures for kidney failure are available but are often administered late because early biomarkers for kidney failure are not available," said study leader, Professor Prasad Devarajan, of the Cincinnati Children's Hospital.
You may also be interested in...
Office of New Drugs Director Peter Stein said in an interview that a large amount of coronavirus-related work is arriving at the FDA, but so far staff are keeping up.
Akero’s FGF21 analog yields 63%-72% relative hepatic fat reduction in Phase IIa study; the company awaits biopsy data hoping to see a fibrotic benefit. Also, Genfit says COVID-19 pandemic should not significantly delay its Phase III NASH readout.
US Vice President Mike Pence and Medicare administrator Seema Verma want academic and university hospital laboratories to send their de-identified COVID-19 test data results, daily, to the Department of Health and Human Services. Commercial and private labs are exempt from the request, as they already share their coronavirus test results with the government.